van Wering ER - Search Results

1

Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.

Pieters R, Huismans DR, Loonen AH, Peters GJ, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Pieters R, et al. Among authors: van der does van den berg a, van wering er. Leuk Res. 1992 Sep;16(9):873-80. doi: 10.1016/0145-2126(92)90033-4. Leuk Res. 1992. PMID: 1405718

2

Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.

Kaspers GJ, Wijnands JJ, Hartmann R, Huismans L, Loonen AH, Stackelberg A, Henze G, Pieters R, Hählen K, Van Wering ER, Veerman AJ. Kaspers GJ, et al. Among authors: van wering er. Eur J Cancer. 2005 Jun;41(9):1300-3. doi: 10.1016/j.ejca.2005.02.026. Eur J Cancer. 2005. PMID: 15869873

3

Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study.

Appel IM, Kazemier KM, Boos J, Lanvers C, Huijmans J, Veerman AJ, van Wering E, den Boer ML, Pieters R. Appel IM, et al. Leukemia. 2008 Sep;22(9):1665-79. doi: 10.1038/leu.2008.165. Epub 2008 Jun 26. Leukemia. 2008. PMID: 18580955 Clinical Trial.

4

Prognostic significance of peanut agglutinin binding in childhood acute lymphoblastic leukemia.

Kaspers GJ, Veerman AJ, Van Wering ER, Van Der Linden-Schrever BE, Van Zantwijk CH, Van Der Does-Van Den Berg A, Pieters R. Kaspers GJ, et al. Among authors: van zantwijk ch, van der linden schrever be, van der does van den berg a, van wering er. Leukemia. 1996 Apr;10(4):675-81. Leukemia. 1996. PMID: 8618446

5

In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia.

Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk CH, Smets LA, Van Wering ER, Van Der Does-Van Den Berg A. Kaspers GJ, et al. Among authors: van zantwijk ch, van der does van den berg a, van wering er. Blood. 1997 Oct 1;90(7):2723-9. Blood. 1997. PMID: 9326239 Free article.

6

Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.

Kaspers GJ, Pieters R, Van Zantwijk CH, Van Wering ER, Van Der Does-Van Den Berg A, Veerman AJ. Kaspers GJ, et al. Among authors: van zantwijk ch, van der does van den berg a, van wering er. Blood. 1998 Jul 1;92(1):259-66. Blood. 1998. PMID: 9639525 Free article.

7

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.

Pieters R, den Boer ML, Durian M, Janka G, Schmiegelow K, Kaspers GJ, van Wering ER, Veerman AJ. Pieters R, et al. Among authors: van wering er. Leukemia. 1998 Sep;12(9):1344-8. doi: 10.1038/sj.leu.2401129. Leukemia. 1998. PMID: 9737681

8

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

Ramakers-van Woerden NL, Pieters R, Loonen AH, Hubeek I, van Drunen E, Beverloo HB, Slater RM, Harbott J, Seyfarth J, van Wering ER, Hählen K, Schmiegelow K, Janka-Schaub GE, Veerman AJ. Ramakers-van Woerden NL, et al. Among authors: van drunen e, van wering er. Blood. 2000 Aug 1;96(3):1094-9. Blood. 2000. PMID: 10910927 Free article.

9

Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.

Zwaan CM, Kaspers GJ, Pieters R, Ramakers-Van Woerden NL, den Boer ML, Wünsche R, Rottier MM, Hählen K, van Wering ER, Janka-Schaub GE, Creutzig U, Veerman AJ. Zwaan CM, et al. Among authors: van wering er. Blood. 2000 Oct 15;96(8):2879-86. Blood. 2000. PMID: 11023525 Free article.

10

Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991.

Kamps WA, Veerman AJ, van Wering ER, van Weerden JF, Slater R, van der Does-van den Berg A. Kamps WA, et al. Among authors: van weerden jf, van der does van den berg a, van wering er. Leukemia. 2000 Dec;14(12):2240-6. doi: 10.1038/sj.leu.2401964. Leukemia. 2000. PMID: 11187915 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page